← SynDRA
BUCLADESINE
SynDRA canonical compound SYN0009489 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PRKACA |
|---|
| Mechanism of action | Adenosine receptor agonist |
|---|
| Indication | skin ulcer |
|---|
| Disease area | dermatology |
|---|
All known targets
Mechanisms of action (all sources)
- CAMP stimulant
- Adenosine receptor agonist
- adenosine receptor agonist, camp stimulant
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PDE3A
- PDE4D
- ACHE
- KCNH2
- NPY2R
- NPY1R
- NPSR1
- MLNR
- MC4R
- MC3R
- MAOA
- KAT2A
- NTSR1
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- GNAS
- NR3C1
- OPRD1
- GLP1R
- OPRK1
- TBXA2R
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- SLC29A1
- RXFP2
- RXFP1
- RGS4
- PTH1R
- PTGS2
- PTGS1
- PLK1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
ATC classes
- C01C · CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Cross-references
Synonyms
- Dibutyryl cAMP
- dbcAMP
- Cyclic AMP dibutyrate
- bucladesine sodium
- bucladesine sodium salt
- Bucladesina
- Dibutyryl camp
- DT-5621
- NSC-143108
- Bucladesine sodium
- Actosin (TN)
- Dibutyryl-cAMP
- Dibutyryl cyclic AMP
- dBcAMP
- Dibutyryl-3',5'-AMP
- Dibutyryl 3',5'-cyclic AMP
- Bucladesine [INN]
- 3',5'-Cyclic AMP dibutyrate
- Bucladesinum
- Dibutyryladenosine cyclic monophosphate
- Dibutyryl cyclic 3',5'-adenylic acid
- Dibutyryl cyclic adenosine monophosphate
- Dibutyryl adenosine 3',5'-monophosphate
- Dibutyryl adenosine 3',5'-cyclic phosphate
- Actosin
- Dibutyryladenosine 3',5'-cyclic monophosphate
- Dibutyryl cyclic adenosine 3',5'-monophosphate
- Cyclic dibutyryl AMP
- 63X7MBT2LQ
- DBC-AMP
- N(6),2'-O-dibutyryl cAMP
- CHEBI:50095
- N(6),O(2')-dibutyryl cAMP
- AMP N6-2'-O-dibutyrate
- N(6),2'-O-dibutyryl cyclic AMP
- Bucladesine (INN)
- N(6),O(2')-dibutyryl cyclic AMP
- N6,O2'-Dibutyryl cyclic AMP
Look up BUCLADESINE in the interactive SynDRA portal →